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Abstract of the Dissertation 
 
 Many persons with Parkinson’s disease (PD) experience difficulty turning that 
can lead to freezing of gait, falls, and an increased risk of fall-related injuries.  We 
hypothesized, based on previous literature, that turning difficulty and freezing during 
turning may be related to deficits in the ability to switch from one motor pattern to 
another (Chapter 2).  We further hypothesized that deficits in oculomotor control, 
particularly in the case of voluntary saccades, also contribute to the pathogenesis of 
turning difficulty since turning is normally initiated with an eye movement (Chapter 3).   
Finally, we hypothesized that current treatment approaches including pharmacological 
and surgical interventions would improve turning performance and oculomotor 
performance in individuals with PD (Chapter 4).  
 To determine whether individuals with PD have trouble switching motor patterns 
with the eyes and whether they experience similar deficits in the lowerimb, we tested 
healthy controls and persons with PD during an orientation switch task.  The PD group 
delayed orientation switching that was attributable to bradykinesia, and there was a 
correlation in the amount of impairment across body parts. These results suggest that 
while individuals with PD may take longer to switch from one motor pattern to another, 
bradykinesia may be the driving factor as opposed to an internal deficit in the ability to 
switch motor programs.  Regardless of mechanism, delays in switching motor patterns 
may play a role in freezing and turning difficulty. 
 To determine if oculomotor function is abnormal in PD during turning and 
whether this contributes to turning difficulty, participants with PD and healthy controls 
performed in-place 90º and 180° turns.  Turn performance was worse in PD (i.e., longer 
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time to turn, more steps) and those with PD made more saccades during the turns. 
Further, the saccade initiating the turn was smaller, slower, and exhibited altered timing 
relative to the first step of the turn in those with PD compared with controls. Finally, 
saccade performance was correlated with turn performance in those with PD.  Our results 
suggest that the oculomotor strategy used by those with PD is altered and less effici nt as 
compared with controls, and that oculomotor dysfunction may be a contributing factor in 
turning difficulty.   
To determine if therapeutic interventions could improve oculomotor function and 
related turning performance, we tested individuals with PD and deep brain stimulation 
(DBS) of the subthalamic nucleus.  Gait parameters and turn duration improved with both 
levodopa therapy and DBS, but only DBS was successful in improving concurrent 
oculomotor function.  The amplitude and velocity of the first saccade improved with 
DBS, while the latency of the first saccade decreased relative to the onset of head rotation 
and the first step.  
Taken together, these studies corroborate previous knowledge that voluntary 
saccades are dysfunctional in PD. Further, these studies relate oculomotor impairment to 
a functional task and give insight into the role of therapeutic interventions for improving 
turning difficulty in PD.  These results also provide support for using visual cueing to 
improve turning performance and therefore, future research should examine the efficacy 
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Chapter 1: Introduction 
 Parkinson’s disease (PD) is a progressive neurodegenerative condition that affects 
nearly 1.5 million people in the U.S.  PD is primarily a disease of the basal ganglia with 
pathophysiology characterized by selective degeneration of dopaminergic neurons in the 
substantia nigra pars compacta and accumulation of alpha-synuclein “Lewy bodies” 
throughout the brain.  While the disease also presents with non-motor symptoms, the four 
cardinal motor symptoms of tremor, rigidity, postural instability, and bradykinesia 
combine in a motor disorder that can severely limit mobility, activities of daily living, 
and quality of life. Among the myriad motor disturbances associated with PD, 
impairments in gait are the most common cause of disability.  Forward walking is 
impaired through a reduction in gait velocity and stride length, while gait transitions such 
as initiation, navigating obstacles, and turning elicit further dysfunction.  Turning 
difficulty (TD) is extremely problematic as turning is very common during locomotion 
and activities of daily living but is a primary trigger for freezing of gait(FOG), often 
leading to falls 1. This is significant as falls that occur during turning are eight times more
likely to result in a hip fracture than falls during straight line walking 2, contributing to a 
3.2 fold greater risk of hip fractures in PD compared with age-matched individuals 
without PD 3.  It is clear that addressing TD in individuals with PD would offer lower risk 
for injury and improved function, yet the underlying causes of TD are not well 
understood, limiting our ability to offer therapeutic strategies to those affected.   
Eye and Limb Control in PD 
 According to Mink’s center-surround hypothesis of basal ganglia function,4 
decreased availability of dopamine and overactivity of the sub-thalamic nucleus (STN) in 
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PD lead to excessive inhibition of desired and undesired movements. Bradykinesia, 
hypokinesia, and in severe cases, akinesia result and can be observed during limb 
movements, functional tasks, and even during eye movements.  For example, hypokinesia 
can include undershooting targets during reaching tasks,5 micrographia,6 and reduced 
stride length during gait.  Bradykinesia is evident during a multitude of movements 
including gait, large amplitude ballistic movements, tasks requiring accur y, and object 
tracking tasks.7 The oculomotor system is similarly affected, albeit differentially 
depending on the nature of the task.  Reflexive, or visually guided saccades, are largely 
unaffected in the early stages of PD,8 but show reduced gain and increased latency during 
later disease stages.9,10  Deficits in smooth pursuit can be observed in milder patients 
during tasks where the subject is required to follow a slowly oscillating target.11 Finally, 
voluntary saccades, defined as eye movements that are internally generated as opposed to 
eye movements in response to an external visual stimulus, appear to be the most affected
as deficits can be measured in early stages of PD and are observed before deficits in 
reflexive saccades.12  In summary, voluntary saccades in people with PD are slower and 
smaller than those of control subjects.8,12-15     
Motor Pattern Switching in PD 
 Beyond the aforementioned impairments, individuals with PD also experience 
difficulty in selecting and executing new motor patterns16,17 along with difficulty 
planning and performing sequential18 and simultaneous motor acts.19  It is hypothesized 
that FOG may be a manifestation of such difficulties in switching between motor 
programs, and we suggest that TD and related freezing episodes are examples of this.  
Multiple studies have reported motor switching difficulty in the upper extremity.  Plotnik 
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et al.20 found that patients with PD have impaired ability to process motor responses to 
successive stimuli, while Inzelberg et al.21 confirmed this with a similar upper extremity 
task and also showed that motor switching deficits were not correlated with men al 
switching deficits, hypothesizing separate mechanisms. During upper extr mity point-to-
point and reversal movement tasks, muscle activation, kinetics, and kinematics were 
affected in subjects with PD.22  In a study by Leis et al.23, when persons with PD were 
required to change a planned action they showed substantially pronounced decrements in 
movement performance, such as slowness and greater variability, indicating th  
modifying a planned action affects subsequent motor execution.  Difficulty changing 
motor patterns has also been noted beyond the upper extremity.  In studying the sit-to-
stand task in PD and controls, Mak and Hui-Chan 24 propose that slowness in PD patients 
could be attributed to difficulties in switching direction from flexion to extension at the 
bottom of task.  Finally, in a study of oculomotor switching, the ability to respond to 
unanticipated changes in target amplitude was well maintained in PD, probably due to the 
benefits of external cueing associated with this type of tasks, but the ability to respond to 
unanticipated changes in target direction was decreased, characterized by gr ater 
variability in latency and in accuracy.  This study suggests that changes in saccade 
direction may rely on the basal ganglia. Overall, there is a large body of literature 
supporting deficits in the ability to modify and switch between motor plans, but none of 
these studies have been performed in the lower extremity specifically or with the eyes.  
 Turning in Healthy Controls and PD 
 Visual information plays a key role in locomotion and therefore impairments in 
visual processing increase locomotor dysfunction.  It has been shown that older adults 
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with visual impairments (i.e.,  loss in visual acuity) fall more frequently than those 
without visual impairments,25-27 and clear differences in gaze behavior have been 
demonstrated between older adult fallers and non-fallers during obstacle navigation 
tasks.28  Visual information is important for turning as well. During turns, studies on 
healthy controls show that a top-down rotation sequence is used whereby the eyes ar th  
first to rotate.  This initial saccade, combined with a subsequent head turn, provides a 
shift of gaze to a position aligned with the direction of travel. This initial change in aze 
is then followed by rotation of the head, trunk, and feet. 29-32 This sequence is thought to 
provide the central nervous system with an external, or global, reference f ame that is 
used to control body movement in space such that one goes where one is looking.31,33   
 While turning has been well described in healthy controls, few studies have 
focused on turning in PD.  In a case report, Morris et al.34 noted that their subject used an 
increased number of steps and a narrower base of support compared to a control subject.  
He also displayed reduced movement of the pelvis and upper trunk during turning.  Stack 
et al.35 noted that individuals with a history of freezing or falls used a greater number of 
steps to turn and appeared unstable during turns.  Recent work has demonstrated that 
subjects with PD tend to turn en bloc, i.e. rotating the head and trunk simultaneously 
rather than in sequence, and require greater time to turn.36-38  The work of Crenna et al.36 
is particularly interesting because it reveals that turning deficits are pres nt even in 
individuals with mild PD who as of yet have no alteration or impairment in their stra ght 
walking.  This suggests that turning difficulty may affect individuals with PD even from 
a very early stage of the disease when other symptoms are not yet apparent.  Although 
oculomotor control is found to be dysfunctional in PD during isolated saccade tasks, no 
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research has been done to date to characterize how this translates to turning and impacts 
turning kinematics. 
Therapeutic interventions  
 Multiple studies have examined the effect of interventions on oculomotor function 
in persons with PD. The efficacy of levodopa, the most commonly prescribed medication 
for PD, in improving saccade function is still a matter of debate.  Saccade amplitude 
appears to be largely unaffected by levodopa,39,40 while saccade latency decreases during 
voluntary saccades 41,42 and increases during reflexive saccades.42,43  On the other hand, 
deep brain stimulation (DBS) has proven very beneficial for improving saccade function 
in PD.  Improvements in gain and latency during both voluntary and reflexive saccades 
have been measured when STN DBS is turned on vs. off.44-47  The effect of therapeutic 
interventions on turning has not been as widely studied.   
Scope of Thesis 
 This research was designed to understand the contribution of oculomotor 
impairments to locomotor dysfunction in PD.  In summary, chapter 2 examines the 
correlation between oculomotor and lower limb impairments in PD, chapter 3 describes 
the impact of oculomotor dysfunction on turning in both PD and controls, and chapter 4 
studies the effect of interventions on turning performance and related oculomotor contr l 
in PD.   
Specific Aim 1: (Chapter 2) 
To determine whether individuals with PD have difficulty switching movement direction 
during movements of the eyes and lower limbs.   
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Hypothesis 1a:  Individuals with PD will display deficits in the ability to change 
movement orientation with the eyes and lower limbs as compared with healthy controls. 
Hypothesis 1b:  Deficits in the ability to change movement orientation of the eyes will be 
related to ability to change movement orientation of the lower limb, indicative of a 
similar level of impairment across different body parts. 
Specific Aim 2: (Chapter 3) 
 To determine whether eye movements during turning are impaired in individuals with 
PD who have difficulty turning during walking, and to determine whether characteristi s 
of the saccade that initiates a turn are predictive of ensuing turn performance. 
Hypothesis 2a:  Individuals with PD will demonstrate slower, smaller saccades at turn 
initiation and will make more saccades during the turn compared to controls.   
Hypothesis 2b: The amplitude, velocity, and latency of the saccade initiating a turn will 
be predictive of the time required to execute the turn.  We expect turns that are initi t d 
with slower, smaller, and later saccades will take longer to complete. 
Specific Aim 3: (Chapter 4) 
To determine the independent and combined effects of medication and DBS of the STN 
on saccadic eye movements during turning and turning performance in persons with PD. 
Hypothesis 3a: Both anti-Parkinson medication and STN DBS will independently 
improve the amplitude and timing of the saccade initiating turns and turning 
performance, but STN DBS will result in greater improvements than medication. 
Hypothesis 3b: Improvements in saccade performance during turning with DBS will be 
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Difficulty switching between motor programs is a proposed cause of motor blocks in 
Parkinson disease (PD). Switching from one movement to another has been studied in the 
upper extremity and during postural control tasks, but not yet in the eyes and lower limb 
in PD. The purpose of this study was to compare movement orientation switching ability 
between people with PD and age-matched controls (CON) and to determine if switching 
ability is correlated between the eyes and lower limb. Twenty-six persons with PD and 19 
age-matched controls participated. Movement orientation switching was studied in a 
seated position with the head fixed in a chinrest.  In response to a randomly generated 
tone, participants switched from a continuous back-and-forth movement in either the 
horizontal or vertical orientation to the opposite orientation as quickly as possible.  Low r
limb movements were performed with the great toe pointing back and forth between 
targets positioned on a 45º angled floor platform. Eye movements were back and forth 
between the same targets.  Eye and lower limb switch time was reduced in PD  (p<0.01), 
but after normalizing switch time to movement velocity, no differences existed between 
PD and CON.  Eye and lower limb switch times were correlated in PD (r=0.513, p<0.01) 
but not in CON.  In PD, switch time and movement velocity of the lower limb, but not 
the eyes, correlated with bradykinesia and postural instability/gait.  Our results suggest 
that individuals with PD experience movement switching deficits with both the eyes and 







 Many persons with Parkinson disease (PD) experience bradykinesia and akinesia 
that often lead to functional decline including decreased mobility, freezing of gait, and a 
higher risk of fall-related injuries.  According to the center-surround hypothesis, basal 
ganglia dysfunction in PD may lead to excessive inhibition of desired and undesired 
movements,1 leading to difficulty with selection and execution of the desired movement.   
This difficulty has been cited as a mechanism underlying problems with changing from 
one motor program to another,2-4 with extreme difficulties in switching motor programs 
perhaps contributing to the freezing phenomenon.5 As freezing of gait is quite often 
triggered by turning, we hypothesize that difficulties in switching between motor patterns 
in order to change direction of movement may underlie the turning difficulties noted in 
many individuals with PD.  Such impairments related to switching movement direction 
have been reported for upper extremity movements and postural control tasks.4,6,7 Pfann 
et al.7 even noted pauses, perhaps analogous to the freezing of gait sometimes triggered 
by turning, at the points of direction change during upper extremity movements.  Specific 
impairments related to changing directions have also been hypothesized to contribute to 
difficulties with sit to stand movements in individuals with PD.8 
 When considering direction changes, particularly during locomotion, one should 
not overlook the role of eye movements.  Saccadic eye movements play an important role 
in locomotion as they provide a shift in gaze toward the direction of travel and initiate the 
top-down rotation sequence characteristic of a normal turning pattern.9-11 Saccadic eye 
movements, however, are impaired in PD, as evidenced by a large body of evidence.  
Early work in persons with PD showed prolonged fixation times, bradykinesia, and 
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akinesia during rapid alternating gaze shifts between two fixed targets.12 Several more 
recent studies have demonstrated that people with PD make slower and smaller voluntary 
saccadesthan control subjects.13-15 The basal ganglia (BG) circuitry may be particularly 
important for changing saccade direction,16 and saccade dysfunction is associated with 
turning difficulty in persons with PD.17 During both 90 and 180 degree turns, the saccade 
initiating the turn is hypometric and displays altered timing relative to turn onset when 
compared with healthy controls.      
To our knowledge, deficits in ability to change movement directions of the eyes 
and lower limbs have yet to be examined in the same individuals with PD.  Therefore, the 
purpose of this investigation was to confirm whether individuals with PD have difficulty 
switching between two movement orientations with the eyes and lower limbs, and to 
determine if the ability to switch movement orientation with the eyes is correlated with 
switching ability in the lower limb.  We hypothesized that deficits in the ability to change 
movement orientation with the eyes and lower limbs would be noted in individuals with 
PD, and that the deficits in the eyes and limbs would correlate with one another, 
indicating a similar amount of decline in orientation switch ability across different body 
parts.  Confirmation of our hypotheses would support an overlap between oculomotor 
and lower limb control in the dysfunctional BG and provide important insights into the 
nature of eye and limb control in PD.      
2. Methods 
2.1 Participants 
 Twenty-six individuals with idiopathic PD (17 men, 9 women; age = 70.2 ± 10.5; 
PD duration 8.4 ± 6.0 years, Hoehn & Yahr stage = 2.3 ± 0.4; MDS-UPDRS III score = 
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41.0 ± 11.1) and 19 age-and gender-matched controls (11 men, 8 women; age = 67.7 ± 
10.6 years) participated.  Sample size was based on a-priori power analysis using witch 
time pilot data; 20 subjects per group would provide 87% power to detect a 0.7 effect size 
using a two-tailed, 2-way ANOVA (p = 0.05). Individuals with PD were recruited from 
Washington University School of Medicine’s (WUSM) Movement Disorders Center.  
Controls were recruited from the Volunteers for Health Database, posted flyers, and other 
WUSM volunteer databases.   All subjects met the following inclusion criteria: aged 30 
years or older, normal central (except for PD in the PD group) and peripheral 
neurological function, able to stand independently for at least 30 minutes and walk 
independently without an assistive device, no history of vestibular disease and no 
evidence or history of dementia.   Exclusionary criteria included: serious medical 
condition other than PD, use of neuroleptic or other dopamine-blocking drug, use of drug 
that might affect balance such as benzodiazepines, evidence of abnormality on brain 
imaging (previously done for clinical evaluations-not part of this research), history or 
evidence of other neurological deficit, and history or evidence of orthopedic, muscular, or 
psychological problem that may affect task performance. Additionally, participants with 
PD were included based on a diagnosis of “definite PD” by a board certified neurologist, 
as previously described by Racette et al.18 based upon established criteria19,20 and were 
excluded if they had received surgical management of PD (e.g. deep brain stimulation).  
All subjects gave informed consent to perform experimental procedures approved by th  
Human Research Protection Office at WUSM. 
2.2 Experimental procedures 
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 All procedures were performed in the Locomotor Control Laboratory at WUSM. 
Participants with PD were tested OFF medication, i.e. after a 12-hour withdrawal of all 
anti-Parkinson medications.  Before testing procedures commenced, the Movement 
Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) Motor 
Subscale III was administered according to Goetz et al.21 by a trained rater. The MDS-
UPDRS-III is a measure of severity of PD motor symptoms, as well as physical 
disability, and includes measures of rigidity, gait, tremor, hand/arm and leg movements 
(bradykinesia), speech, and facial expressions. The modified Hoehn and Yahr scale was 
used to evaluate disease severity in PD.22  FOG was assessed using the Freezing of Gait 
Questionnaire (FOG-Q), 23 with total FOG-Q score representing overall FOG severity, 
and freezers identified as those who reported freezing of gait at least once per week on 
item three or the questionnaire. 
 During the protocol, each participant performed eye and lower limb movement 
tasks while in a seated position.  Lower extremity tasks were performed with the 
dominant limb. For all movement tasks, four white targets were placed on a black angled
platform (45º relative to the floor) located on the floor in front of the subject. Targets 
were positioned 20 centimeters apart such that eye movements between targets would be 
approximately 25 degrees (Figure 1).  Each subject was seated with his head resting in a 
chinrest to minimize head movement and angled downward such that the platform was 
positioned in the center of the visual field.  The platform was centered in front of the 
subject at a distance that allowed for comfortable movement of the lower limb. To 
investigate the ability to switch movement orientation (switch task), participants began 
the task by moving either their eyes or lower limb (pointing with the big toe) back and 
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forth as quickly as possible between two targets (either horizontally or vertically).  Upon 
hearing an auditory tone, participants were instructed to switch movement orientation as 
quickly as possible and continue moving back and forth in the new orientation. Multiple 
orientation switches, including both horizontal-to-vertical (HV) and vertical-o-horizontal 
(VH) switches, were performed at random times during each trial with 4-6 orientation 
switches per 30 second trial. Auditory cues were triggered by the first author by pressing 
a button which sounded the signal.  Throughout each trial, the interval between switches 
was random as that the tester did not time the interval between switch cues and made an 
effort to vary the time interval from switch to switch.   
 To control for differences in reaction time between PD and CON, simple reaction 
times (RT) of the lower limb and eyes were tested. Each participant began with eyes 
fixated or great toe positioned on a target centered between the 4 peripheral targets used 
for the switch task.  Upon hearing a tone, the participant reacted as quickly as possible t  
move either left, right, up, or down, as instructed prior to each trial.   To control for 
differences in movement velocity between PD and CON, participants also perform d 
three 10 second trials of back and forth movements of the eyes or lower limb, moving as 
quickly as possible between the horizontal targets without switching orientations so that 
average movement velocity could be determined.  For all tasks, participants were given 
the opportunity to practice the task and data collection commenced when the participant 
was comfortable performing the task. 
2.3 Data collection and processing 
 Lower limb movements were captured using an eight camera, passive marker, 3-
dimensional, high-resolution motion capture system sampling at 100 Hz in Cortex 
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software (Motion Analysis Corporation, Santa Rosa, CA).  One retro-reflective marker 
was positioned at the base of the great toe.  The motion capture system was calibrted 
both statically (calibration frame) and dynamically (wand) prior to each data collection 
session.  Ocuolmotor data were captured using a head-mounted infrared binocular eye 
tracking system (Applied Sciences Laboratory, Bedford, MA) and electrooculography 
(EOG).  Oculomotor data were captured synchronously at 1000Hz on the same PC 
workstation with kinematic data in Cortex software.  The infrared eye tracking system 
was calibrated for each participant using a two step process. First, a nine-point relative 
points methods was used to calibrate the eye tracking system. Then, participants 
performed saccades of known amplitudes in four directions (up, down, left, right) to 
allow conversion of analog data (millivolts) into angle data (degrees).  
 Lower limb marker data and analog data were filtered using 4th order low-pass 
Butterworth filters.  Marker data were filtered in Cortex with a cut-off frequency of 6 Hz 
while analog data were filtered in MotionMonitor (Innsport, Chicago, IL) with a cut-off 
frequency of 20 Hz.  A global coordinate system was defined in MotionMonitor with the 
positive X-axis pointing anteriorly, positive Y-axis pointing to the left and positive Z-axis 
pointing upward vertically.  Toe marker kinematic data and filtered analog data were 
exported for further processing in custom written MATLAB software (The Mathworks, 
Inc, Natick, MA).   
 For the orientation switch task, switch time was defined as the time interval 
between the auditory tone and the beginning of first full amplitude movement in the new 
orientation. As each trial contained multiple VH and HV switches, VH and HV switches 
were measured separately and an average switch time was determined for each switch 
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orientation.  For the RT tasks, RT was defined as the time interval between auditory tone 
and movement onset (lower limb movement exceeding 5 mm from origin and eye 
movements exceeding 0.5 degrees from origin). For the movement velocity task, 
movement velocity was calculated as the number of back and forth cycles completed 
during a measured time period multiplied by the average movement amplitude across all 
of the cycles within the trail.  Finally, to control for the effect of movement v locity, 
switch times were normalized to movement velocity by multiplying the two measur s. 
Individual trials were excluded from analysis if artifacts in oculomotor data ue to blinks, 
prolonged closure of eyelids, or other factors precluded measurement.  Remaining trials 
within a condition were averaged to obtain a single data point for each subject for each 
task. 
2.4 Data Analysis 
 Independent Student’s t-tests were used to compare between-group differences in 
movement velocity, movement amplitude, and normalized switch time for both the eyes 
and lower limb, and a Bonferroni correction was used to control for multiple 
comparisons, bringing the level of significance for the t-tests to p<0.0045. A mixed 
model was used to test the effect of group, segment (eye vs. lower limb), and the group-
segment interaction on switch time and RT.  Segment was treated as a repeated measure.  
Pearson’s correlation coefficients were used to test the correlation between eye and lower 
limb switch times as well as the correlation between switch time and movement veloci y. 
Spearman’s rank order correlations were used to examine correlations between 
movement parameters (amplitude, velocity, switch time) and FOG and the MDS-UPRS 
III.  The criterion for statistical significance was set at p<0.05 for all analyses. 
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3. Results  
 Eye movements in the vertical plane could not be captured for a number of 
participants (13 PD and 2 CON). Therefore, only movement tasks in the horizontal plane 
and VH orientation switches are reported. Age did not differ between PD and CON (t = 
.799, p = 0.429), nor did RT (F = 1.703, p = 0.199), although RT was slower in the lower 
limb (F = 28.343, p < 0.001).  Movement velocity was not statistically different between 
PD and CON for the eyes (t = 1.505, p = 0.140), but was decreased in PD for the lower 
limb (t = 3.710, p = 0.001).  There was a significant group effect for switch time (F = 
20.99, p <0.001), but neither the main effect of segment nor the group-segment 
interaction were significant (F=2.386, p = 0.130; F = 0.143, p = 0.707, respectively).  
Although switch time was significantly different between groups, normalized switch time 
did not differ significantly between groups for the eyes (t = 1.683, p = 0.100) or lower 
limb (t = 1.138, p = 0.261).   During the movement velocity task, average lower limb and 
eye movement amplitudes closely approximated the expected values based on target 
placement (20 cm/ 25 degrees apart), and there were no group differences for th  eyes (t 
= 0.453, p = 0.653) or lower limb (t = 1.949, p = 0.058).  Eye and lower limb 
performance data are displayed in Table 1. 
  Across all participants, switch times of the eyes and lower limb were 
significantly correlated (r = 0.425, p = 0.004), but normalized switch times of the eyes 
and lower limb were not significantly correlated (r = 0.257, p = 0.088). Within PD, eye 
and lower limb switch time did not correlate significantly (r = 0.286, p = 0.186) but 
normalized switch times correlated significantly (r = 0.513, p = 0.007). Within CON, 
neither correlation was significant (switch time, r = 0.089, p = 0.719; normalized switch 
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time, r = -0.058, p = 0.812) (Figure 2).   In PD, FOG was correlated with lower limb 
velocity (ρ = -.483, p = 0.013), amplitude (ρ = -0.552, p = 0.007), and switch time (ρ = 
0.503, p = 0.009).  Total MDS-UPDRS-III scores correlated with lower limb switch time 
(ρ = 0.502, p=0.009), velocity (ρ = 0.551, p = 0.004), and amplitude (ρ = -0.606, p = 
0.001).   MDS-UPDRS-III scores were also divided into sub-scores reflecting tremor 
(items 3.15 – 3.18), rigidity (item 3.3), bradykinesia (items 3.4 – 3.8), and postural 
stability and gait (PIGD, items 3.9 – 3.13).  PIGD correlated with lower limb switch time 
(ρ  = 0.558, 0.003), velocity (ρ  = -0.617, p = 0.001) and amplitude (ρ = -0.430, p = 
0.032).  Bradykinesia correlated with lower limb switch time (ρ  = 0.412, p = 0.036) and 
velocity (ρ  = -0.493, p = 0.010).  Eye switch time and velocity did not correlate 
significantly with any of the MDS UPDRS III sub-scores.  These correlations are shown 
in Figure 3.  Finally, switch time and movement velocity were significantly correlated in 
the eyes (r = -0.587, p < 0.001) and in the lower limb (r = -0.749, p< 0.001) across all 
participants. 
 Comparing freezers and non-freezers, groups did not differ in terms of movement 
velocity (eye, t = 1.045, p = 0.306; lower limb, t = 1.134, p = 0.268) or amplitude (eye, t 
= 0.007, p = 0.995; lower limb, t = 0.852, p = 0.403).  The main effect of eye vs. lower 
limb was significant for RT (F = 21.248, p < 0.001) with RT being slower in the lower 
limb. Both the main effect of group (F = 0.039, p = 0.845) and the interaction (F = 1.343, 
p = 0.258) were not significant for RT. Switch time main effect of group (F = 1.081, p = 
0.309), eye vs. lower limb (F = 1.936, p = 0.177), and the interaction (F = 3.247, p = 




 This study sought to determine whether the ability to switch movement 
orientation with the eyes and lower limbs is impaired in PD and whether orientation 
switch ability is similar between the eyes and lower limbs.  In summary, persons with PD 
took longer to switch movement orientation with both the eyes and lower limb, and 
displayed a reduction in lower limb movement velocity. When normalizing switch time 
to movement velocity, the significant group effects of switch time were negated.  Across 
both PD and CON, eye switch time correlated significantly with lower limb switch time, 
and in persons with PD, FOG, UPDRS, PIGD, and bradykinesia correlated significantly 
with lower limb function, while oculomotor function did not correlate with these 
measures.  There were no differences between PD freezers and non-freezers in terms of 
switch time, movement velocity, or movement amplitude 
 Our hypothesis was supported in that persons with PD required 37% and 41% 
more time to switch orientation with their eyes and lower limb, respectively, compared to 
controls. However, since eye and lower limb movement velocities were slower in PD 
compared with CON, we normalized orientation switch times to movement velocity. In 
doing so, we noted that normalized switch times were similar between PD and controls, 
indicating that if PD were to move at the same velocity as the controls, their orientation 
switch ability may be comparable for both the eyes and lower limbs. As hypothesized, 
normalized lower limb switch times explained 26% of the variance in normalized eye 
switch times in PD, but this relationship did not hold true for controls.  
 Our finding of prolonged switch times in PD corroborates previous research.  In 
the upper extremity, Almeida et al.24 observed delays in switching between two 
coordination patterns in the upper extremity, while Plotnik et al.6 showed that people with 
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PD respond poorly to movement modifications.  To our knowledge, this is the first study 
to report such findings in the lower extremity and eyes.  Further, previous studies in th  
upper extremity did not account for movement velocity.  Herein, we demonstrate that 
accounting for movement velocity negates the group differences in orientation sw tch 
ability.  Thus, observed deficits in the ability to switch movement direction/orietat on in 
our study and others, indicative of a deficit in motor program switching, may be simply a 
function of global bradykinesia.  Regardless, it is clear that the overall time required to 
change from one movement paradigm to another in response to an external stimulus is 
greater in PD.  This difficulty may contribute to FOG which is often triggered by a 
change in movement, such as switching from straight walking to turning. The modest 
delay in switching between simple motor programs observed in the present study may 
manifest in a much longer delay or freeze when the motor programs are more 
complicated (i.e. gait).  A delay in switching could also be a contributing factor in falls, 
as a delay in selecting and executing the proper motor response to an unanticipated 
perturbation or change in body position may not allow enough to time to catch oneself 
before a point of no return. Finally, our study supports previous work showing deficits in 
oculomotor function in PD. Visual information plays an important role in gait and people 
with PD show deficits in saccade performance that relate to impaired turning 
performance17 and may contribute to FOG and falls.  
 While the basal ganglia are often described as having distinct loops for 
oculomotor and motor control, evidence suggests that the subthalamic nucleus (STN) 
may play key roles in the control of both eye and limb movements, indicating overlap of 
the oculomotor and motor loops. Some neurons within the STN respond to voluntary 
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saccades as well as limb movements.25 The timing and characteristics of saccade-related 
potentials in STN suggest that these cells are responsible for broad non-specific 
inhibitory output to inhibit unwanted motor programs, whether for the eyes or the 
limbs.26 Disruption of this inhibitory output from the STN could account for impairments 
in voluntary saccades27 and limb movements.  Abnormal STN output may also contribute 
to difficulty turning that can trigger FOG, as evidenced by the fact that STN deep brain 
stimulation can alleviate off-period freezing.28-30 The apparent overlap between 
oculomotor and motor control in the basal ganglia provides a potential anatomical 
substrate where a pathophysiological disruption could contribute to impaired eye and 
limb movements and also to turning difficulties.  Our data suggest that eye and lower 
limb switching are mildly correlated, supporting the potential for overlap between 
oculomotor and lower limb control by the basal ganglia and a global bradykinesia that 
appears to influence eye and limb movements similarly.  In line with a center surround 
hypothesis,1 the common bradykinesia of the eyes and lower limbs may be due to over-
activity of the subthalamic nucleus leading to excessive inhibitory output from the basal 
ganglia. In support of a global bradykinetic cause for delays in switching movement 
orientation in the tasks we studied, our global bradykinesia score obtained from the 
MDS-UPDRS-III correlated with lower limb orientation switch times, as did the PIGD 
score. 
 While we conclude that differences in switch time between PD and CON are 
driven by bradykinesia, it is important to consider alternative hypotheses.  Since the 
switch task involved reacting to an auditory stimulus, differences in switch times could 
be attributed to differences in RT between PD and CON.  However, RT did not differ 
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between groups for either the lower limb or eyes, thus RT is unlikely to have contributed 
to group differences in switch time. An alternative hypothesis to our bradykinesia 
explanation is that persons with PD suffer from a deficit in the ability to select and 
execute a new or different motor program, and that this deficit is at least partially 
independent of bradykinesia. If this were the case, we would expect group differences in 
switch time to remain even after controlling for movement velocity (normalized switch 
times), indicated that bradykinesia does not fully explain the effect of group on switch
time. However, this was not the case as normalized switch times were very similar 
between PD and CON for both the eyes and lower limb.  Further support for our 
bradykinesia hypothesis is that movement velocity and switch time were highly 
correlated in both the eyes and lower limb across all subjects, and that there were no 
differences between freezers and non-freezers in the ability to switch movement 
orientation.  
4.1 Limitations 
 During the movement velocity and orientation switch tasks, participants were 
provided with visual cues in the form of targets.  A large body of existing literatur  
supports the use of various types of visual cueing strategies for improving movement in 
PD.  Therefore, it is possible that movement amplitude and switching ability were 
enhanced in PD by the presence of targets.  Additionally, the lower limb and eye 
movements required for the tasks herein were of relatively small amplitude (20cm for the 
lower limb and 25 degrees for the eyes).  Since the performance of those with PD 
compared well with controls in terms of movement amplitude, it is possible that the in er-
target distance chosen was too small to elicit hypokinetic movement in PD.  
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4.2 Conclusions and future directions 
 Switching between movement contexts is impaired in PD and affects not only 
upper and lower limb movements, but eye movements as well, and the severity of 
dysfunction is similar between eyes and lower limb.  It appears that global bradykinesia 
may be a factor affecting switching ability in PD. Future work should explore mve ent 
switching ability of the lower limbs during more complex and functionally relevant tasks, 
such as during locomotion. 
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Figure 1:  
Experimental set-up. (A) Participants were seated in a chair with their head positioned in 
a chinrest to minimize head movement and with their head tilted downward.  A binocular 
head-mounted eye tracking device was secured to their head in this position.   A black 
platform was positioned on the floor in front of the subjects. The platform was angled 45 
degrees to the floor with round white targets positioned on the face of the platform.   (B) 
Configuration of targets for the orientation switch task. (C) Configuration of targets for 










































Figure 3: Correlations of lower limb switch time (left column) and movement velocity 


























Table 1.  Eye and Lower Limb Performance Data.  
                    
Measure     PD     (n)  Controls    (n)   
Eye RT (sec)     0.293 ± 0.061     26     0.286 ± 0.034    18    
Foot RT (sec)     0.360 ± 0.064    26  0.336 ± 0.062     19 
Eye Velocity (degrees/sec)   48.05 ± 15.9  26  54.84 ± 13.5  19 
Foot Velocity (cm/sec)   34.40 ± 12.6    25 † 47.89 ± 11.2  19 
Eye Amplitude (degrees)   24.8 ± 4.2  26  25.1 ± 0.9  19     
Foot Amplitude (cm)    18.5 ± 0.01  25  19.3 ± 0.01  19 
Eye Switch Time (sec)   1.00 ± 0.294   26 † 0.731 ± 0.134   19 
Foot Switch Time (sec)   1.11 ± 0.366    26 † 0.789 ± 0.126  19  
Normalized Eye Switch Timea  45.25 ± 12.42  26  39.56 ± 9.26  19 
Normalized Foot Switch Timeb  34.46 ± 7.34  26  36.96 ± 7.17  19   
Values are means ± standard deviations. 
a,b Arbitrary units 
* Significant group effect, p < 0.05 
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Background. Persons with Parkinson’s disease (PD) experience difficulty turning, leading 
to freezing of gait and falls. We hypothesized that saccade dysfunction may relate to 
turning impairments, as turns are normally initiated with a saccade. Obj ctive. Determine 
whether saccades are impaired during turns in PD and if characteristics of the turn-
initiating saccade are predictive of ensuing turn performance. Methods. 23 persons with 
PD off medication and 19 controls performed 90 and 180 degree in-place turns to the 
right and left.  Body segment rotations were measured using 3-D motion capture nd 
oculomotor data were captured using a head-mounted eye tracking system and 
electrooculography. Total number of saccades and the amplitude, velocity, and timing of 
the first saccade were determined. Results. Turn performance (turn duration, number of 
steps to turn) was impaired in PD (p<0.05).  PD performed more saccades, and the 
velocity and timing of the first saccade was impaired for both turn amplitudes (p<0.05).  
Amplitude of the first saccade was decreased in PD during 180 degree turns. Turn 
duration correlated with oculomotor function. Characteristics of the first saccade 
explained 48% and 58% of the variance in turn duration for 90 and 180 degree turns, 
respectively. Conclusions. Turning performance is impaired in PD and may be influenced 
by saccade dysfunction. An association between saccade function and turnig
performance may be indicative of the key role of saccades in initiating proper turning 
kinematics. Future work should focus on improving saccade performance during 






 Parkinson’s disease (PD) is a progressive neurodegenerative disease that is 
associated with a reduction in mobility, with problems that include difficulty turning.  
Turning difficulties can lead to freezing of gait (FOG), falls, fear of falling, and social 
withdrawal.1-3 Falls that occur during turning are eight times more likely to result in hip 
fracture than falls during straight line walking.4  Furthermore, individuals with PD have a 
3.2 fold greater risk of hip fracture than age-matched individuals without PD.5  In 
addition to the large personal cost of turning difficulties, hip fractures represent a 
substantial financial burden to society, with the cost of hip fracture care in individuals 
with PD totaling approximately $192 million per year in the United States.5,6  
 Studies focusing on turning have noted that individuals with PD require more 
steps and take longer to complete a turn than healthy controls.7-11  Those with PD who 
report turning difficulty also have a higher incidence of freezing of gait and f lls.10,12  
Furthermore, the timing of segmental rotations during turn initiation is altered in PD.  
This has been termed “en bloc” turning and is characterized by the near simultaneous 
rotation of the head, trunk, and pelvis and reduced relative rotations between adjacent 
segments.9,13-15  Other measures of poor turn quality have been observed in those with PD 
including a wider turn arc16, narrowed step width11,16,17, and higher variation in step 
duration compared with controls.16   
 It is evident that visual information plays an important role in the control of 
locomotion and turning.  Clear differences in gaze behavior and stepping performance 
have been demonstrated between older adult fallers and non-fallers.18  In addition, 
training of eye movements has been shown to improve locomotor performance in 
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individuals with cerebellar damage.19  Several studies in healthy individuals have shown 
that the eyes participate in a top-down rotation sequence such that the eyes are th  first to 
turn, followed by the head, trunk, and then the feet.20-23  The initial saccade during a turn, 
in combination with subsequent head movements, provides a shift of gaze to a position 
aligned with the direction of travel.  Gaze shifts precede shifts in center of mass (COM) 
trajectory during turning and unexpected perturbations of gaze cause delays in COM 
movement to steer the body along the desired trajectory.24   
 While eye movements have been measured in healthy adults during turning tasks, 
it is unclear how eye movements relate to turning performance in individuals with PD.  
During head-fixed tasks, saccadic eye movements have been shown to be abnormal in 
those with PD, including prolonged fixation times, bradykinesia, and akinesia during 
rapid alternating gaze shifts between two fixed targets.25  Several more recent studies 
have demonstrated deficits in control of voluntary saccades in people with PD, 
consistently noting that saccades are slower and smaller than those of control subjects.26-
30  Briand et al29 reviewed a series of 15 studies of voluntary saccades and noted that all 
but one of these studies reported voluntary saccade performance inferior to that of control 
subjects in individuals with PD.  Therefore, we hypothesize that saccadic eye movements 
performed during turns are also likely abnormal and may contribute to impaired turn 
performance.  A disruption of the normal top-down rotation sequence by poor saccade 
timing or decreased saccade amplitude may contribute to the altered turning kinematics 
reported in those with PD.  Hence, the purposes of this study were to determine whether 
saccadic eye movements during turning are impaired in individuals with PD and to 
41 
 
determine if characteristics of the saccade that initiates a turn are predictive of ensuing 
turn performance.  
METHODS 
Participants 
 Twenty-three individuals with idiopathic PD and 19 age- and gender-matched 
controls participated in this investigation.  Individuals with PD were recruited from a 
database of patients from Washington University School of Medicine’s (WUSM) 
Movement Disorders Center.  Control participants were recruited from the Volunteers for 
Health Database, posted flyers, and other healthy volunteer databases associated with 
WUSM.   All subjects met the following inclusion criteria: aged 30 years or olde, normal 
central (except for PD in the PD group) and peripheral neurological function, able to 
stand independently for at least 30 minutes and walk independently without an assistive 
device, no history of vestibular disease and no evidence or history of dementia.   
Exclusionary criteria included: any serious medical condition other than PD, use of 
neuroleptic or other dopamine-blocking drug, use of drug that might affect balance such 
as benzodiazepines, evidence of abnormality on brain imaging (previously done for 
clinical evaluations-not part of this research), history or evidence of other neurological 
deficit, such as previous stroke or muscle disease, and history or evidence of orthopedic, 
muscular, or psychological problem that may affect task performance during the study. 
Additionally, participants with PD were included based on a diagnosis of “definite PD” 
by a board certified neurologist, as previously described by Racette et al. (1999) based 
upon established criteria (Calne et al. 1992, Hughes et al. 1992) and were excluded if 
they had received surgical management of PD (e.g. pallidotomy or deep brain 
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stimulation).  All subjects gave informed consent to perform experimental procedures 
approved by the Human Research Protection Office at WUSM. 
Experimental Procedures 
 All study procedures were performed in the Locomotor Control Laboratory at 
WUSM. Participants with PD were tested OFF medication, i.e. after a 12-hour 
withdrawal of all anti-Parkinson medications.  Before testing procedures commenced, the 
Movement Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) 
Motor Subscale III was administered according to Goetz et al31 by a trained rater. The 
MDS-UPDRS-III is a measure of severity of PD motor symptoms, as well as physical 
disability, and includes measures of rigidity, gait, tremor, hand/arm and leg movements 
(bradykinesia), speech, and facial expressions. The modified Hoehn and Yahr scale also 
was used to evaluate disease severity in PD.32   
 During the experimental protocol, participants completed in-place turns of 90 
degrees and 180 degrees amplitude.  Instructions were given to perform the turns in a 
comfortable and normal fashion.  No specific auditory or visual cues were provided to 
cue turn onset or completion other than directing subjects to “turn 90 degrees to face the
wall beside you” or “turn 180 degrees to face the wall behind you”, accordingly.  
Participants were instructed to begin the movement anytime after receiving the turn 
direction instruction of left or right for the given trial.  Turns were completed to both the 
right and left in randomized order and all 90° turns were completed prior to beginning the 
block of 180° turns.  Participants completed a minimum of 5 turns in each direction.  
Data quality was visually monitored in real time and additional turns were completed as 
needed to insure an adequate number of quality trials for analysis. 
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 Full body kinematic data were captured using an eight camera, passive marker, 3-
dimensional, high –resolution motion capture system (Motion Analysis Corporation, 
Santa Rosa, CA) sampling at 100 Hz in Cortex software (Motion Analysis Corporation, 
Santa Rosa, CA).  Thirty-eight retro-reflective markers were positioned  the head (top 
of head, back of head, left ear, right ear), trunk (left and right acromion, right scapula, 
sternal notch, xyphoid process, 7th cervical vertebra, 12th thoracic vertebra), pelvis (left 
and right anterior superior iliac spine, left and right posterior superior iliac spine, 
sacrum), both legs (greater trochanter, anterior thigh, medial and lateral femoral condyle, 
tibial tuberosity, front of shank, medial and lateral malleolus) and both feet (calcaneus, 
navicular, distal 2nd metatarsal). Ocuolmotor data were captured using a head-mounted 
infrared binocular eye tracking system (Applied Sciences Laboratory, Bedford, Ma) and 
electrooculography (EOG).  Oculomotor data were captured synchronously at 1000Hz on 
the same PC workstation with kinematic data in Cortex software.   
Data Processing 
 Individual kinematic marker data and analog data were filtered using 4th order 
low-pass Butterworth filters.  Marker data were filtered in Cortex with a cut-off 
frequency of 6 Hz while analog data were filtered in MotionMonitor (Innsport, Chicago, 
IL) with a cut-off frequency of 20 Hz.  Global and segment coordinate systems wre 
defined in MotionMonitor with the positive X-axis pointing anteriorly, positive Y-axis 
pointing to the left, and positive Z-axis pointing upward vertically.  Rotations of the head, 
trunk, pelvis, and feet about global Z were extracted using a Z-X-Y Euler sequence.  
Subsequently, kinematic angle data and filtered analog data were exported for further 
processing in custom written MATLAB software (The Mathworks, Inc, Natick, MA).   
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 Time of onset for segment rotations (relative to the global coordinate system) was 
determined by identifying the first frame at which the rotation reached fiv  degrees above 
baseline.  Similar criteria were used to identify turn offset, defined as the fram  at which 
the rotation came within five degrees of maximal, final position. Eye tracker and EOG 
data were used to identify and measure saccades occurring just prior to and during turn 
performance.  Saccades were identified visually and later confirmed to be true saccades if 
the maximum velocity of the eye movement exceeded 30 degrees/sec.33,34  Onsets and 
offsets of the first saccade associated with each turn were identified visually. Using these 
time points, saccade amplitude, peak velocity, and timing of the first saccade rel tive to 
head and foot rotations were calculated.  Example trials are shown for an individual w th 
PD and a control in Figure 4.  
 Individual trials were excluded from analysis if eye position or body segment 
rotations about the global Z-axis were not static for at least 1000ms prior to turn nset.  
Trials were also excluded if artifacts in oculomotor data due to blinks, prolonged closure 
of eyelids, or other factors precluded measurement of the initial saccade.  Remaining 
trials within a condition (90 or 180 degrees) were averaged to obtain a single data point 
for each subject. Left and right turns were combined for analysis as turn performance did 
not differ between leftward and rightward turns.    
Data Analysis 
 Independent Student’s t-tests were used to compare between-group differences in 
turn performance and oculomotor performance during both 90 and 180 degree turns. Our 
primary variables of interest were the amplitude and velocity of the saccade initiating the 
turn, the total number of saccades performed during the turn, and the timing of the first 
45 
 
saccade relative to onsets of head and foot rotations.  The latencies between the first 
saccade and head/foot rotations were normalized to the duration of the first gait cycle and 
are reported as a percentage of the first gait cycle time. We also emply d a linear 
regression model with turn duration as the dependent variable and number of saccades, 
initial saccade velocity and normalized timing of the saccade relative to turn onset as the 
independent variables to identify the amount of variance in turn performance accounted 
for by characteristics the saccade initiating the turn. Saccade amplitude and the 
normalized timing of the saccade relative to head rotation onset were not included in th  
model as they were highly correlated with the included variables.  The criterion for 
statistical significance was set at p<0.05. 
RESULTS  
 Demographic data are displayed in Table 1.  Data from three participants included 
in the 90 degree turn analysis could not be included in the analysis for the 180 degree 
turn due to poor oculomotor data quality. Conversely, one participant was included in the 
180 turn analysis but omitted from the 90 degree analysis for similar reasons.  Regardless 
of turn type, age did not differ between PD and controls.         
 Turn performance was impaired in PD compared with controls, with both 90 and 
180 degree turns requiring more steps (p<0.05) and a greater time to complete (p<0.01).  
PD also performed a greater number of saccades during their turns, and the peak velocity 
of the initial saccade was slower in PD for both 90 and 180 degree turns (p<0.01).  The 
amplitude of the initial saccade was less in PD than in controls for 90 degree turns only 
(p<0.01).  The normalized latency between start of the first saccade and start of the first 
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step (Norm E-F Index) was different between groups, with PD performing the first 
saccade earlier relative to the onset of foot rotation (<0.05, Table 2). 
 The number of saccades, initial saccade amplitude, initial saccade velocity, and 
Norm E-F Index were all significantly correlated with turn duration (Figure 5).  Turn 
duration, which was highly correlated with the number of steps required to turn, was used 
as the dependent variable representing turn performance in our regression analysis. The 
linear regression model, which included both PD and controls, explained a significant 
amount of the variance in turn duration for both 90 degree (R2 = .481, F(3,27)=11.4, p < 
.001) and 180 degree (R2 = .578, F(3,25) = 16.0, p < .001) turns. Table 3 reports the 
unstandardized (B) and standardized (β) regression coefficients for these models.  
 Comparing freezers and non-freezers, turn duration and number of steps were 
greater in subjects who reported freezing of gait at least once per week on item 3 of the 
FOG questionnaire (p<0.05).  Mean values for initial saccade velocity and Norm E-F 
Index differed between freezers and non-freezers, but these comparisons did not reach 
statistical significance. Despite the lack of statistical significance, the effect sizes, 
measured using Cohen’s d, were moderate to large. Effect size for saccade velocity 
between freezers and non-freezers equaled 0.91 for 90 degree turns and 0.52 for 180 
degree turns.  Norm E-F Index effect sizes were 0.8 for 90 degrees turns and 0.86 for 180 
degree turns.   Number of saccades and initial saccade amplitude were similar between 
freezers and non-freezers. Data comparing freezers and non-freezers is pr sented in Table 




 This study sought to determine whether saccadic eye movements performed 
during turning are impaired in individuals with PD and to determine if characteristics of 
the saccade that initiates a turn are predictive of ensuing turn performance.  In 
confirmation of our hypotheses, saccadic eye movements were impaired during turn in 
persons with PD and these impairments were related to turning dysfunction.  Individuals 
with PD used a greater number of saccades to complete both 90 and 180 degree turns, the 
initial saccade was both smaller (180 degrees only) and slower than that of controls, a d 
the timing of the initial saccade relative to the turn onset was altered in those with PD.  
Furthermore, turn performance was impaired in persons with PD and approximately 50% 
of the variance in turn performance was explained by saccade performance across all 
participants. Differences in saccade performance between the 90 and 180 degree turns 
were largely predictable.  The 180 degree turns required approximately twice as many 
saccades as the 90 degree turns and the amplitude of the initial saccade was similar 
between turn magnitudes for both groups.  This suggests that the size of the turn-
initiating saccade is constant for turns of 90 degrees and larger, and that simply more 
saccades are performed for large turns.  Similarly, the delay between the firs  saccade and 
turn onset did not differ between the two turn magnitudes.             
 Previous research widely demonstrates that voluntary saccade performance is 
impaired in persons with PD.25-30  These studies, however, have focused only on simple 
head-fixed tasks or on saccades performed in conjunction with head movements from a 
seated position. Studying the oculomotor system using simple saccade paradigms has 
allowed researchers to better understand basal ganglia disorders using a simple, 
predictable, and well understood motor system. However, little information has been 
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gathered from such studies regarding the implications of oculomotor impairments on 
functional activities in those with PD.  To the best of our knowledge, this is the first study 
to report saccade performance during a more complex, functional task in people with PD.  
Our novel findings support previous work that voluntary saccades are impaired in PD and 
lend support to the idea that the eyes play a key role in turning.  The turning sequence has 
been characterized in healthy controls and consists of a top-down rotation sequence led 
by the eyes and followed by rotations of the head, trunk, pelvis, and feet.20-23  In 
individuals with PD this sequence is impaired, characterized by smaller intersegmental 
rotations and altered timing of segment rotations.9,13,14  The present study reveals that the 
turning sequence in PD is also characterized by a longer than normal delay between the 
first saccade and the initiation of the gait cycle, as well as a smaller and slower saccade at 
the beginning of the turn.  Functionally, this manifests in reduced turn performance.  As 
evidenced by the strong correlations between saccade performance (the number of 
saccades, saccade velocity, and saccade timing) and turn performance (number of steps 
and turn duration), the degree of oculomotor impairment may impact turn quality.     
 Our finding of a greater delay between the initial saccade and the rest of the 
turning sequence in the PD group is contrary to our hypothesis. Expanding the PD en-
bloc turning phenomenon to include eye movements, one would expect the eyes to rotate 
more in sync with the head, trunk and feet, as opposed to our observation of a longer 
latency between the eyes and feet.  Our PD group actually performed the first saccade 
much earlier in the rotation sequence than did the controls, and the longer latencies wre 
unexpectedly associated with a longer turn duration and more steps.  This finding may be
explained by a generalized bradykinesia that affects both the motor and oculomotor 
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systems.  While the basal ganglia are often described as having distinct loops for 
oculomotor and motor control, recent evidence suggests an overlap in control of both eye 
and limb movements by the subthalamic nucleus (STN), as neurons in the STN respond 
to both voluntary saccades and limb movements.35    Therefore, the greater delay between 
eye movement and turn onset seen in PD may be the result of a dysfunctional common 
motor pathway responsible for an overall bradykinetic turn sequence.  Based on this, 
deep brain stimulation (DBS) may prove beneficial for improving turn performance in 
PD by enhancing both eye and limb movements.  Levodopa therapy, the most common 
treatment for those with PD, provides minimal improvement in both turn performance 
and voluntary saccade performance.36,37  However, DBS of the STN in persons with PD 
has shown considerable efficacy in improving motor performance, including gait and 
performance of voluntary and reflexive saccades.38-40.  However, no studies to date have 
examined the effect of DBS on turn performance, nor the effect of DBS on saccade 
function during functional tasks. Therefore, future work should target the effects of STN-
DBS on turn performance and associated oculomotor performance.     
 Studies extending beyond PD corroborate a relationship between oculomotor 
dysfunction and gait impairments; a relationship that appears to be related to risk of 
falling in a range of populations.  In a study comparing elderly individuals who were at 
high risk for falling with those at low risk for falling, a longer delay between horizontal 
saccade initiation and initiation of footlift was observed in the high-risk group during a 
precise walking task.41  Differences in gaze behavior have also been shown between adult 
fallers and non-fallers.18  In patients with progressive supranuclear palsy (PSP), those 
with more severe gaze palsy displayed an altered stepping pattern when navigati g 
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obstacles, placing them at higher risk for trips and falls.42  In our study, subjects who 
reported FOG at least once per week displayed turn performance deficits and altered 
saccade timing and velocity, although the comparison of oculomotor measures failed to 
reach statistical significance, possible due to the small group sizes. Disease severity 
(MDS-UPDRS III) and duration were not different between freezers and no-freezers, 
illustrating that FOG is a specific pathology not present in all PD patients r gardless of 
disease stage or severity.2  While we did not obtain fall history records in this study, FOG 
has been shown to be a risk factor for falling, and thus the freezers in our study likely 
represent a sample of patients at higher risk for falls and fall-related injuries.  Taken 
together, our study and those of other pathological populations suggest a relationship 
between fall risk and gait/oculomotor function.  Therefore, rehabilitation strategies aimed 
at decreasing the risk of falls during ambulation, and in particular during turning, are 
important.  
Cueing has received considerable attention over the past decade as a means of 
improving temporal and spatial parameters of gait in persons with PD.  Rhythmic 
auditory, visual, and attentional cues have been shown to improve stride length and gait 
velocity during straight walking.43-46  However, the ability of cues to improve turning 
performance is less well understood.  When rhythmic auditory cues were used during a 
U-turn task, only step time variability was improved among a number of turn 
performance parameters.16 In contrast, another study found that rhythmic auditory and 
somatosensory cues improved turn time in a functional task (carrying a tray).47  Clearly, 
more work is necessary to determine the effect of cues on turning, and based on the 
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importance of oculomotor function during turning, using cues to promote a more 
appropriate oculomotor strategy during turns should be of interest.    
Limitations 
 One limitation of this study is that saccades were measured using two separate 
measurement systems.  The infrared binocular eye tracking system served as our primary 
measurement tool, with EOG serving a secondary role.  Due to the technical nature of 
measuring pupil and corneal reflections using the infrared system, quality infrared data 
could not be obtained from all participants.  In such cases, EOG data were used for 
analysis.  To verify agreement between these two measurement systems, infrared and 
EOG data were compared using data from participants for whom we had both data sets.  
When comparing the timing, amplitude, and velocity of the initial saccade, values 
obtained from the two systems compared exceptionally well.  Therefore, the authors felt 
confident in pooling data obtained from either measurement system.  Another 
limitation of this study is that measurement occurred in a laboratory setting and thus 
participants were aware that their performance was being monitored.  Hence, it is 
possible that participants’ oculomotor and turning performance may have differed from 
their usual performance in a more natural setting.  The authors think, however, that such 
effects are minimal and would have been experienced similarly by both groups, thus not 
detracting for our findings.   
Conclusions and Future Directions 
 It is evident that turning difficulty is a primary trigger for freezing and falls in PD, 
and our study indicates that impaired voluntary saccades may contribute significantly to 
this problem. Rehabilitative strategies might consider focusing on cueing persons with 
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PD to initiate turns with a more appropriate top-down rotation sequence, initiated by a 
large amplitude saccade prior to commencing the gait cycle.  Accordingly, future 
research should be directed towards studying the effects of cueing and practice on the 
ability to improve saccade performance during turns, and whether such improvements 
offer meaningful improvements in turn performance and related fall risk.  Additionally, 
future work may assess the effects of therapeutic interventions (e.g. deep brain 
stimulation) on such variables.          
Acknowledgements 
 We thank Marie McNeely for assistance with data collection, Brian Morrell for 
assistance with data processing, and Dr. Richard Abrams for assistance with project 
design and pilot testing.  This publication was made possible by R01 HD056015, the 
Barnes Jewish Hospital Foundation, and Grant Number UL1 RR024992 from the 
National Center for Research Resources (NCRR), a component of the National Institutes 
of Health (NIH), and NIH Roadmap for Medical Research. Its contents are solely the 
responsibility of the authors and do not necessarily represent the official view of NCRR 
or NIH.  Additional support came from the St. Louis Chapter of the American Parkinson 
Disease Association (APDA) and the APDA Advanced Center for PD Research at 







Figure 4.  Representative data from individual turn trials showing eye, head, and 
foot rotations in the horizontal plane. 
Panel A: Representative 90 degree turn performed by an individual with PD.  The subject
performed 8 saccades of varying amplitudes during the turn, and required 3 steps to 
complete the turn. Panel B: Representative 90 degree turn performed by a healthy 
control.  The subject performed only 5 saccades during the turn and required only 2 steps 
and less time to complete the turn than the individual with PD. Panel C: Representative 
180 degree turn performed by an individual with PD.  The subject performed 15 saccades 
of varying amplitudes during the turn, and required 5 steps to complete the turn.  Panel D: 
Representative 180 degree turn performed by a healthy control.  The subject performed 8 
saccades of more consistent amplitude than those performed by the individual with PD, 
























Figure 5. Correlations between turn duration and various parameters of saccade 
performance. 
Correlations include all subjects from both the PD and control groups, with Pearson 
correlation coefficients shown in top right of each panel. The left column shows 
correlations of saccade number (A), amplitude of the first saccade (B), velocity of the 
first saccade (C), and normalized timing of the first saccade relative to th  first step (D) 
for 90 degree turns.  The right column (E-H) shows the same correlations for 180 degree 














Table 1. Subject Demographics 
             
    PD (90° turns)        PD (180° turns) Controls  
 
Age (years)   68.7 ±10.2      68.6 ±10.8  68.8 ± 11.4  
Male/Female         14/8       13/7         11/8  
 
PD Characteristics 
Disease Duration (years)    7.4 ± 5.8    6.8 ± 5.6 
Hoehn & Yahr Stage     2.3 ± 0.4     2.3 ± 0.4 
(# in each stage)  Stage  1 = 1  Stage 1 = 1 
    Stage  2= 9  Stage 2= 7 
    Stage  2.5 = 10 Stage 2.5 = 10 
    Stage  3 = 2  Stage 3 = 2 
 
Freezing of Gait Score    5.7 ± 4.8     5.8 ± 5.0 
No. Freezers (FOG 3 ≥ 2)          8            8 
MDS-UPDRS III Score  40.1 ± 11.9    38.7 ± 11.5     


























Table 2. Turn Performance and Oculomotor Performance During 90 and 180 Degree Turns 
_________________________________________________________________________________________________________  
             90° Turns        180° Turns 
Measure          PD   Controls        PD   Controls  
# of Steps     4.3 ± 2.6        * 2.7 ± 0.8   7.7 ± 5.1 * 4.5 ± 0.9 
Turn Duration (seconds)   2.1 ± 0.8        † 1.4 ± 0.5   3.6 ± 1.5 † 2.4 ± 0.7  
 
# of Saccades      4.5 ± 1.7  † 3.1 ± 1.4   8.9 ± 3.2 † 6.0 ± 1.5  
First Saccade Amplitude (degrees)  20.6 ± 8.1  25.7 ± 8.4   17.4 ± 4.6 † 24.7 ± 6.7 
First Saccade Velocity (deg/sec)  219.0 ± 65.6  † 273.1 ± 41.1   206.7 ± 61.2 † 255.3 ± 39.5 
Norm E-H Index (% of 1st gait cycle)  19.4 ± 19.3  11.5 ± 6.1   26.8 ± 25.0 * 13.4 ± 7.2 
Norm E-F Index (% of 1st gait cycle)  45.4 ± 33.9  * 25.4 ± 9.7   52.3 ± 38.1 * 28.1 ± 11.5  
 
Values are means ± standard deviations. 
* Significantly different between groups, p < 0.05 
† Significantly different between groups, p < 0.01 
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Table 3. Results of Linear Regression Analysis 
             
     B  SE (B)  β  p  
90° Turns # Saccades  18.24  6.40  .392  .007 
  Saccade Velocity -.232  .18  -.180  .211 
  Norm E-F Index 94.59  36.93  .329  .015 
 
180 ° Turns # Saccades  18.72  5.79  .407  .003 
  Saccade Velocity -.283  .28  -.248  .048 
  Norm E-F Index 147.01  53.01  .337  .009  
90° Turns, R2 = .481 
180° Turns, R2 = .578
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Table 4. Comparison of Freezers and Non-Freezers 
____________________________________________________________________________________________________________ 
               90° Turns                       180° Turns 
     Freezers (n=8)  Non-Freezers (n=14)  Freezers (n=8)  Non-Freezers (n=12)  
Disease Duration       8.6 ± 7.0      6.7 ± 5.2       8.3 ± 6.7      5.8 ± 4.8 
MDS-UPDRS III Score    40.1 ± 13.1    40.1 ± 11.7     39.9 ± 12.9    37.8 ± 11.0 
 
# Saccades        4.5 ± 2.0      4.6 ± 1.6         9.1 ± 2.6      8.8 ± 3.7 
Saccade Amplitude (degrees)    20.6 ± 8.5    20.7 ± 8.2      18.2 ± 3.4    16.9 ± 5.4 
Saccade Velocity (deg/sec)  183.8 ± 59.8  239.2 ± 61.7    187.7 ± 61.5  219.4 ± 60.2 
Norm E-F Index     61.1 ± 49.0    36.4 ± 18.2      70.8 ± 48.1    40.0 ± 24.8 
Total Steps        6.4 ± 3.6   *     3.1 ± 0.5      11.1 ± 6.7   *     5.4 ± 1.1 
Turn Duration (seconds)      2.8 ± 8.1   †     1.6 ± 0.4         4.7 ±1.7   *     2.8 ± .77  
Values are means ± standard deviations. 
*Significantly different between groups, p < 0.05 
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Background: Persons with Parkinson’s disease (PD) experience turning difficulty, often 
leading to freezing of gait and falls. Visual information plays a significant role in 
locomotion and turning, and while the effects of medication and deep brain stimulation 
(DBS) on oculomotor function have been well documented, the effects of each on 
oculomotor function during turning and on turning itself have yet to be fully elucidated. 
Objective: To determine the separate and combined effects of levodopa and STN DBS on 
turning performance and related oculomotor performance in PD. Methods: Eleven 
subjects with PD and DBS of the subthalamic nucleus performed a seated voluntary 
saccade task and standing 180° turns. Oculomotor data were captured using an infrared 
eye tracking system while segment rotations were measured using 3-D motion capture.  
Results: During the seated saccade task, neither medication nor DBS improved saccade 
amplitude or latency, while DBS alone improved gait velocity and stride length during 
forward walking. During turning, both medication and DBS improved turn performance 
(turn duration) and reduced the number of saccades performed during the turns. DBS 
increased the amplitude and velocity of the saccade initiating the turn while medication 
had no effect. DBS decreased the intersegmental latencies (eye-head, eye-foot, and head-
trunk) but this effect was lost for eye-head and eye-foot after controlling for the duration 
of the first gait cycle. Conclusions: DBS significantly improves turn performance and 
related oculomotor performance while medication has a minimal effect.  These findings 




INTRODUCTION   
 Turning during gait is common and required during normal ambulation and 
activities of daily living.  Individuals with Parkinson’s disease (PD), however, experience 
difficulty turning, leading to freezing of gait (FOG), falls, and fear of falling.1-3  Falls 
during turns are eight times more likely to result in hip fracture than falls during straight 
line walking, and individuals with PD have a 3.2 fold greater risk of hip fracture than 
age-matched individuals without PD.4  Hip fractures represent a substantial financial 
burden to society, with the cost of hip fracture care in individuals with PD totaling 
approximately $192 million per year in the United States.5 
 Recent studies have attempted to elucidate the cause of turning difficulty in PD in 
order to develop strategies to overcome the issue.  Such studies have noted that persons 
with PD require more steps and take longer to complete a turn than healthy controls.6-9 
Additionally, individuals with PD show altered timing of segmental rotations during tur  
initiation, such that their turning strategy is more “en bloc” than healthy controls,8,10-12 
although this finding may not be observed in early PD stages.13  It is also clear that visual 
information plays an integral role in this turning sequence.  In healthy controls, the eyes 
participate in the top-down rotation sequence such that they eyes precede the sequential 
rotations of the head, trunk, and feet.14  In subjects with PD, however, the amplitude of 
the initial saccade is smaller than in healthy controls, a greater number of smaller 
saccades are performed during the turn, and the timing of the initial saccade relativ  to 
the first step is altered.9,13 These oculomotor deficits are consistent with a large body of 
literature supporting voluntary saccade dysfunction in PD.  Prolonged fixation times, 
bradykinesia, and akinesia during rapid alternating gaze shifts have been observed in PD, 
and voluntary saccades are widely described as being smaller and slower in PD.15  In 
68 
 
gaze re-orienting tasks where the eyes rotate in concert with the head to fixate on a lateral 
target, eye-head coordination is found to be abnormal such that both saccades16 an  head 
rotations 16,17 are delayed, hypometric, and slow.   
 Few studies have been done to determine the effects of interventions on turning in 
PD.  While levodopa therapy was effective in improving MDS-UPDRS III scores and 
gait velocity in one study, congruent with previous research,18 the effect on turn duration, 
steps to turn, and the timing of body segment rotations was minimal.19  Similarly, the 
effects of anti-Parkinson medications on saccade function are mixed.  While the 
amplitude of voluntary saccades appears to be resistant to levodopa therapy,20,21 levodopa 
may have a beneficial effect on voluntary saccade latencies22,23 but a negative effect on 
reflexive saccade latencies.23,24  In contrast, the effects of subthalamic nucleus (STN) 
deep brain stimulation (DBS) on turning are more robust and in line with evidence 
showing that DBS improves gait velocity and stride length in PD.25,26  The effects of DBS 
on saccade function are also well documented.  Rivaud-Pechoux et al.27 found a positive 
effect of STN DBS on saccade gain during a memory guided saccade task.  Sauleau et 
al.28 also reported improvements with STN DBS in gain and latency of both saccades and 
gaze during head fixed and head free reflexive saccade tasks, respectively. Final y, Temel 
et al.29,30 found a marked improvement in saccade latency distributions with STN-DBS, 
whereas dopaminergic medication had a negative effect on saccade latency.  
 While the effects of anti-parkinson medication on turning and oculomotor 
function have been reported separately, as well as the effects of DBS on the latter, no 
studies have examined the effect of levodopa on both turning and oculomotor function in 
PD, and only one study has tested the effects of DBS on turning in PD.31 Therefore, the 
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purpose of this study was to determine to separate and combined effects of levodopa and 
STN DBS on turning performance and related oculomotor performance in PD. Based on 
evidence that DBS improves both gait and oculomotor performance in PD, we 
hypothesized that turning performance (time to turn) would be improved with DBS, 
including an increase in initial saccade amplitude and alterations in the timingof the first 
saccade relative to turn onset.  We also hypothesized that levodopa would improve 
turning and related oculomotor function, but to a lesser extent than DBS, and that the 
combination of the two therapies would have an additive effect on turning performance.  
We based the latter hypothesis on a study by Ferrarin et al.26 who showed that levodopa 
and DBS provided an additive benefit in terms of gait speed, stride length, and 
intersegmental range of motion during gait. 
METHODS 
Participants 
 Eleven individuals with idiopathic PD participated in this investigation.  
Participants were recruited from a database of patients from Washington University 
School of Medicine’s (WUSM) Movement Disorders Center.  All participants met the 
following inclusion criteria: aged 30 years or older, bilateral STN DBS and a minimum 
of 3 months post implantation surgery, currently taking levodopa medication, normal 
central (except for PD in the PD group) and peripheral neurological function, able to 
stand independently for at least 30 minutes and walk independently without an assistive 
device, no history of vestibular disease and no evidence or history of dementia.   
Exclusionary criteria included: any serious medical condition other than PD, use of 
neuroleptic or other dopamine-blocking drug, use of drug that might affect balance such 
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as benzodiazepines, evidence of abnormality on brain imaging (previously done for 
clinical evaluations-not part of this research), history or evidence of other neurological 
deficit, such as previous stroke or muscle disease, and history or evidence of orthopedic, 
muscular, or psychological problem that may affect task performance during the study. 
Idiopathic PD was based on a diagnosis of “definite PD” by a board certified neurologist, 
as previously described by Racette et al. 32 based upon established criteria.33,34  All 
participants gave written informed consent to perform experimental procedures approved 
by the Human Research Protection Office at WUSM. 
Experimental Procedures 
 All study procedures were performed in the Locomotor Control Laboratory at 
WUSM, which each participant visited on two separate days.  Participants were test d in 
the “on” state of their anti-Parkinson' medication for the entirety of one of the visits and 
were in the “off” state for the entirety of the other visit (i.e. after a 12-hour withdrawal of 
all anti-Parkinson medications).  The order of these visits was counterbalanced. Within 
each visit, the experimental protocol was performed twice; once with DBS stimulators 
turned on using clinical settings, and once with DBS stimulators turned off.  Again, the 
order of these conditions was counterbalanced within the testing day.  Prior to 
commencing each round of the experimental protocol, the Movement Disorder Society 
Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) Motor Subscale III was 
administered according to Goetz et al.35 by a trained rater. The MDS-UPDRS-III is a 
measure of severity of PD motor symptoms, as well as physical disability, and includes 
measures of rigidity, gait, tremor, hand/arm and leg movements (bradykinesia), speech, 
and facial expressions. The modified Hoehn and Yahr scale also was used to evaluate 
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disease severity in PD36 and the FOG questionnaire (FOG-Q) was assessed to categorize 
freezers and non-freezers.37    
Saccade Task 
 To evaluate simple voluntary saccade function during an eyes only task, 
participants performed saccades to targets positioned 20° to the left and right of a center 
target. The task was performed in a seated position with the participant’s head positioned 
in a chin-rest to minimize head movement and rotation, and the square targets (2.5 cm X 
2.5 cm) were located at eye level on a white wall in front of the subject.  Upon hearing an 
auditory tone, subjects were instructed to react as quickly as possible by performing a 
saccade to one of the lateral targets.  Within each block of trials, the order of left and 
right movements was randomized.  Five trials were performed for each target.
Turning Protocol 
 Following the seated saccade task, participants completed in-place turns of 180° 
amplitude.  Instructions were given to perform the turns in a comfortable and normal 
fashion.  No specific auditory or visual cues were provided to cue turn onset or 
completion other than directing subjects to “turn 180 degrees to face the wall behind 
you.”  Participants were instructed to begin the movement anytime after receiving the 
turn direction instruction of left or right for the given trial.  Turns were completed to both 
the right and left in randomized order. Participants completed a minimum of 5 turns in 
each direction.  Data quality was visually monitored in real time and additional ur s 
were completed as needed to ensure an adequate number of quality trials for analysis. 
 Full body kinematic data were captured using an eight camera, passive marker, 3-
dimensional, high–resolution motion capture system (Motion Analysis Corporation, 
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Santa Rosa, CA) sampling at 100 Hz in Cortex software (Motion Analysis Corporation, 
Santa Rosa, CA).  Thirty-four retro-reflective markers were positioned on the head (top 
of head, back of head, left ear, right ear), trunk (left and right acromion, right scapula, 
sternal notch, xyphoid process, 7th cervical vertebra, 12th thoracic vertebra), pelvis (left 
and right anterior superior iliac spine, left and right posterior superior iliac spine, 
sacrum), both legs (greater trochanter, anterior thigh, lateral femoral condyle, tibial 
tuberosity, front of shank, lateral malleolus) and both feet (calcaneus, navicular, dist l 2nd 
metatarsal). Ocuolmotor data were captured using a head-mounted infrared binocular eye 
tracking system (Applied Sciences Laboratory, Bedford, MA) and electrooculography 
(EOG).  Oculomotor data were captured synchronously at 1000Hz on the same PC 
workstation with kinematic data in Cortex software.   
Walking Task 
 To confirm the clinical benefit of both the medication and DBS stimulation, 
subjects performed 3 trials of forward walking at a comfortable, self selected pace across 
a 5 m instrumented, computerized GAITRite walkway (CIR Systems, Inc., Havertown, 
PA). Gait velocity and stride length were used as measures of gait function.  
Data Processing 
 Individual kinematic marker data and analog data were filtered using 4th order 
low-pass Butterworth filters.  Marker data were filtered in Cortex with a cut-off 
frequency of 6 Hz while analog data were filtered in MotionMonitor (Innsport, Chicago, 
IL) with a cut-off frequency of 20 Hz.  Global and segment coordinate systems wre 
defined in MotionMonitor with the positive X-axis pointing anteriorly, positive Y-axis 
pointing to the left, and positive Z-axis pointing upward vertically.  For the turning task,
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rotations of the head, trunk, pelvis, and feet about global Z were extracted using a Z-X-Y 
Euler sequence.  Subsequently, kinematic angle data and filtered analog data were 
exported for further processing in custom written MATLAB software (The Mathworks, 
Inc., Natick, MA).  
 For the turning task, we characterized the timing of the rotation sequence by 
identifying the time of onset of each segment yaw rotation (relative to theglobal 
coordinate system).  This was determined by identifying the first frame at which the yaw 
rotation reached five degrees above baseline.  Similar criteria were used to id ntify turn 
offset, defined as the frame at which the yaw rotation came within five degrees of 
maximal, final position. Eye tracker and EOG data were used to identify and measure 
saccades occurring just prior to and during turn performance.  Saccades were identifi d 
visually and later confirmed to be true saccades if the maximum velocity of the eye 
movement exceeded 30 degrees/sec.38,39 Onsets and offsets of the first saccade associated 
with each turn were identified visually. Using these time points, saccade amplitude, peak 
velocity, and timing of the first saccade relative to head and foot rotations were 
calculated.  Our primary variables of interest for the turning task were the amplitude and 
velocity of the saccade initiating the turn, the total number of saccades perform d during 
the turn, turn duration, and the timing of the first saccade relative to the onset of the first 
step. Secondary variables of interest included the timing of the turning sequence, i.e. th  
timing of each body segment (head, trunk, pelvis) relative to the first step of the turn.   
 For the seated task, the first saccade following the auditory cue was measured in a 
similar manner.  Variables of interest were the latency of saccade onset with respect to 
the auditory cue and saccade amplitude. 
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 Individual trials were excluded from analysis if eye position or body segment 
rotations about the global Z-axis (during the turn task) were not static for at least 1000ms 
prior to turn onset.  Trials were also excluded if artifacts in oculomotor data due to blinks, 
prolonged closure of eyelids, or other factors precluded measurement of the initial 
saccade.  Remaining trials were averaged to obtain a single data point for each 
combination of medication and DBS state within each subject.  For the turning and seated 
tasks, left and right trials were combined for analysis as performance did not differ 
between leftward and rightward trials. 
Data Analysis 
 A two-way repeated measures ANOVA was used to evaluate the main effectso  
medication status and DBS status as well as the interaction between the two for all 
variables of interest. The criterion for statistical significance was set at p<0.05. 
RESULTS  
 Demographic data are displayed in Table 1; performance data are displayed in 
Tables 2 and 3.  The main effect of DBS on MDS-UPDRS III scores was significant 
(F=23.4, p=0.001), with DBS improving MDS-UPDRS III scores. Neither the main effect 
of medication status (F=0.199, p=.665) nor the interaction (F=1.252, p=0.289) were 
significant.  DBS had a main effect on gait velocity (F=5.44, p=0.042) and stride length
(F=4.89, p=0.51), as both improved with DBS turned on.  The main effect of medication 
on gait velocity and stride length (F=0.047, p=0.83, F=0.248, p=0.629, respectively), as 
well as the interaction between medication and DBS for the same two gait vari bles 
(F=0.006, p=0.94, F=0.085, p=0.78, respectively), were not significant. 
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 Both DBS and medication improved turn duration as the main effects of both 
were significant (F=7.77, p=0.019; F=5.08, p=0.048, respectively) while the interaction 
was not (F=4.073, p=0.071). Similarly, DBS and medication each lowered the number of 
saccades performed during turns (main effects: F=24.932, p=0.001; F=12.71, p=0.005, 
respectively) and the interaction of DBS and medication was significant for number of 
saccades (interaction F=7.70, p=0.02). For the amplitude of the first saccade performed 
during the turn, the main effect of DBS was significant (F=36.515, p<0.001) as DBS 
increased first saccade amplitude, while the main effect of medication (F=0.823, 
p=0.386) and the interaction (F=0.725, p=0.414) were not. The main effect of DBS on 
saccade velocity was significant (F=9.803, p=0.011) as DBS increased saccade velocity, 
while the main effect of medication (F=1.551, p=0.241) and the interaction (F=0.593, 
p=0.459) were not.   
 In characterizing the timing of the rotation sequence, there was a main effect of 
DBS for the eye-head (F=6.416, p=0.03), eye-foot (F=10.435, p=0.009), and head-trunk 
(F=6.382, p=0.030) latencies as DBS decreased the latencies between segment rotatio s. 
Neither the main effects of medication nor the interactions were significant.  When 
dividing the latencies by the duration of the first gait cycle to obtain normalized lat ncies 
in order to control for turning speed, each of the above main effects of DBS were 
removed except for the normalized head-trunk latency (F=12.039, p=0.006).  Finally, 
during the seated tasks, there were no significant effects of DBS (F=1.224, p=0.297; 
F=1.653, p=.231) or medication (F=0.294, p=0.601; F=0.803, p=0.394) in regards to 




 The purpose of this study was to determine the independent and combined effects 
of levodopa and DBS on measures of turning performance and related oculomotor 
performance in PD.  In summary, both DBS and levodopa had a profound effect on 
turning duration as well as the number of saccades performed during the turn.  DBS also 
improved MDS-UPDRS III scores and gait parameters (velocity and stride length), while 
levodopa did not.  Secondly, the amplitude and velocity of the first saccade performed 
during the turn was increased significantly by DBS but was not improved with levodopa.  
Finally, the inter-segmental latencies between the eyes, head, trunk, and feet were 
decreased by DBS but not by levodopa, however this effect was largely eliminated when 
we controlled for turning speed.   
 To the best of our knowledge, this is the first study to address the therapeutic 
effects of DBS on turning in PD as well as the first to measure the effects of DBS on 
oculomotor function during a functionally relevant task.  Our findings are consistent wi h 
previous research that shows an improvement in motor symptoms, particularly gait, with 
DBS.  DBS was effective in increasing gait velocity by approximately 13% and stride 
length by approximately 10% in our study. Our findings of improved turning duration 
and concomitant improvements in oculomotor performance during turns are novel yet 
anticipated based on the efficacy of DBS in improving saccade function and gait in 
previous studies.  Previous work in our lab (Lohnes and Earhart, 2011) showed that 
persons with PD turn slower and with more steps than healthy, age-matched controls, a d 
that turn performance is correlated with oculomotor function such that individuals who 
perform later, larger, faster, and fewer saccades turn better.  Similarly, d ta herein 
suggest that improved oculomotor performance associated with DBS is correlated with 
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improved turn performance.  Neither of these studies, however, address a cause-and-
effect relationship between oculomotor and turn performance.  Since the oculomotor 
system initiates the turning sequence, we hypothesize that saccades occurring before and 
early in the turn sequence may affect subsequent turning kinematics, but it is also 
plausible that improvements in oculomotor function (as measured herein) are driven by 
improved turn performance. For example, a decrease in the number of saccades 
performed during the turn may be an effect of shortened turn duration and increased turn 
speed. This is evidenced by the data in that the number of saccades performed per second 
was greater with DBS ON compared with DBS OFF (2.34 saccades/sec vs. 1.94 
saccades/sec, respectively).  Thus, if our subjects had turned for the same length of time 
with DBS both OFF and ON, they would have performed more saccades in the same 
timeframe with DBS ON.  Beyond the role of the oculomotor system, other factors re 
also likely to contribute to the improved turn performance noted with DBS.  DBS 
improved overall MDS-UPDRS-III scores as well as bradykinesia, rigidity, and PIGD, 
measures that are all independent from saccade function but could affect turn 
performance.  DBS also produced a shortening of intersegmental latencies (ye-head, 
eye-foot, head-trunk). Again, while DBS-related improvements in saccade function could 
have contributed to this, the decreased intersegmental latencies are most likely due to the 
increased speed with which subjects were able to complete the turns during DBS 
stimulation, hence shortening all aspects of the turn sequence.  This hypothesis is 
supported by the fact that intersegmental latencies were similar when e controlled for 
the duration of the first gait cycle. 
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 Levodopa was not nearly as effective as DBS in improving gait and turning. 
Turning duration and the number of saccades performed during the turns were improved 
with medication, albeit to a lesser extent than with DBS, while gait velocity and stride 
length, saccade amplitude and velocity, and turn sequence variables were unaffected by 
levodopa. Subjects in this study did display a top-down rotation sequence in regards to 
the timing of rotation onset of the various segments (eye-head, head-trunk, trunk-foot), 
but it is possible that the turning sequence used herein is still more “en bloc” than the 
pattern utilized by healthy controls.  The presence of a top-down rotation sequence in the 
current study is in contrast to Hong & Earhart8,19 which reported en bloc timing in a 
group of non-DBS PD patients, and are in line with Anastasopoulos et al.13 who observed 
a top-down rotation sequence in a sample of mild PD patients.  On the other hand, our 
study was similar to Hong & Earhart19 in that these timing characteristics did not change 
when levodopa was taken.  Conclusions related to the effects of levodopa in the present 
study must be interpreted cautiously as these may be explained by a dosing issue, as 
MDS-UPDRS III scores also did not improve with levodopa.  Although we used 
clinically prescribed doses of levodopa, these doses are most likely much less than the 
maximally effective dose, as is often the case with DBS patients. Following DBS 
implantation and resulting motor improvement, levodopa doses are often reduced 
significantly to limit dyskinesias.  As a result, the failure of levodopa to improve many of 
the oculomotor and turning measures herein may be due to the limited doses used.  
 While DBS improved walking and turning performance, it did not improve 
saccade performance during the seated saccade task, which is contrary to previous 
research showing beneficial effects of DBS on saccade performance.  Therwer , 
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however, some methodological differences between ours and previous studies.  Previous 
studies examined the effects of DBS on both voluntary (memory guided saccades, anti-
saccades) and reflexive saccades using protocols where the saccade was cu d visually 
(either the appearance of a lateral target or the disappearance of the central target).  In our 
study, we used an auditory cue to initiate the saccade.  Furthermore, our targets were 
static in that they remained in view for the duration of the test.  In contrast to mem ry-
guided or anti-saccade paradigms where the subjects perform saccades to a target-less 
location, our subjects made saccades toward a static visual target which may have served 
as an external cue that facilitated performance.      
Limitations 
 There are a few limitations related to this study.  First, the use of clinical levodopa 
doses was intended to increase the external validity of our study, but it is possible that in 
doing so we missed potential therapeutic effects that would otherwise have been seen 
with a maximally effective dose.  As such, the reported effects of medication on turn and 
oculomotor performance should be taken with caution and should not be extrapolated 
beyond persons with PD and STN-DBS.  It is likely that levodopa dosing is higher in 
persons with PD but without DBS, and thus levodopa may have a more profound effect 
on turning and related oculomotor performance than reported herein.  It is also possible 
that the effect of medication on persons with DBS differs from the effect of medication 
on those without DBS.   Further, we used a 12 hour levodopa withdrawal period before 
OFF medication testing and a 45 minute rest period between DBS stimulator changes and 
data collection.  A 12 hour medication withdrawal period may have only resulted in a 
partial off-medication state but due to the study design, a longer withdrawal period was 
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not practical as full washout can take multiple days. In regards to DBS, it has also been 
shown that 90% of changes in motor performance (UPDRS-III scores) occur within 45 
minutes of DBS being turned off, and changes after DBS is turned on occur more 
quickly, with 90% of changes in motor performance occurring in 15-20 minutes.41 While 
our washout periods may not have resulted in full OFF or ON states, we feel the resulting 
medication and DBS conditions are representative of clinical conditions.  Another 
limitation of this study is that we did not consider specific electrode placement within the 
STN when selecting participants, resulting in some likely heterogeneity among subjects 
in regards to stimulation localization within the STN.  While saccade-related neurons are 
clustered in the ventral STN,41,42  PD motor symptoms such as gait and balance appear to 
respond similarly to dorsal and ventral STN DBS.43  As such, functional tasks that 
significantly involve the oculomotor system (e.g. turning) may be best ameliorat d by 
DBS in the ventral STN. Selecting sub-groups of patients based on electrode placement 
(i.e., dorsal vs. ventral STN) may offer further understanding of the effect of STN DBS 
on oculomotor function during turning, but cognitive function must be considered in such 
studies as response inhibition has been shown to decrease with ventral STN DBS.44 
Finally, during the seated saccade task, we used a novel paradigm with static targets and 
an auditory cue. This may explain the lack of effect of both DBS and medication on 
saccade amplitude and latency.    
Conclusions/Implications 
 In conclusion, STN DBS is largely effective in improving both straight walking 
and turning performance in PD, including increases in saccade amplitude and a decreased 
number of saccades required to complete the turn.  These results add to the growing 
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number of known benefits offered by DBS, and add to the functional applicability of 
previous research that has found beneficial effects of DBS on saccades and gaze during 
seated tasks.  Future work may aim to define optimal DBS electrode placement for 
patients whose primary motor complications include freezing during turning, or a history 
of falls during turns.   
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Figure 6. Representative data from individual turn trials showing eye-in-head, head-over-
ground, and foot-over-ground rotations about the z (vertical) axis. Left column = DBS 
OFF; Right column = DBS ON; Top row = Meds OFF; Bottom row = Meds ON.  All 
turns are to the right and are initiated with the right foot.  Both DBS and levodopa 


























Figure 7.  Effects of DBS and levodopa on oculomotor performance during turns. 
*Significant main effect of DBS (p<0.05); † Significant main effect of Medication 




































Table 1. Subject Demographics 
             
Age (years)    66.6 ±7.1  
Male/Female          8/3        
Disease Duration (years)  15.6 ± 6.6 
Hoehn & Yahr Stage (OFF/OFF)   2.6 ± 0.6 
Freezing of Gait Score    5.8 ± 4.4 
# of Freezers *           3 
 
Disease Severity   DBS OFF/ DBS ON/ DBS OFF/ DBS ON/ 
               Meds OFF Meds OFF Meds ON Meds ON  
MDS-UPDRS III  45.81 ± 10.0 32.5 ± 8.8 43.0 ± 9.5 30.2 ± 6.0 
             
Values are means ± standard deviations. 




























Table 2. GAITRite and Seated Saccade Task Data 
            
      DBS OFF    DBS ON  Mean ± SD  
GAITRite Data 
 
Gait Velocity (cm/s)          
 Meds OFF    94.9 ± 30.1  106.8 ± 20.5  100.8 ± 25.3 
 Meds ON    93.9 ± 23.6  106.5 ± 16.5  100.2 ± 20.1 
 Mean ± SD    94.4 ± 26.9     * 106.6 ± 18.5 
 
Stride Length (cm)    
 Meds OFF  103.8 ± 25.2  113.4 ± 17.9  108.6 ± 21.6 
 Meds ON  104.2 ± 20.4  115.7 ± 15.7  110.0 ± 18.1 
 Mean ± SD  104.0 ± 22.8     * 114.6 ± 16.8 
 
Seated Saccade Task 
 
Saccade Latency (ms)          
  
 Meds OFF  335.8 ± 98.0  335.0 ± 104.0  335.4 ± 101.0 
 Meds ON  335.3 ± 89.3  355.6 ± 95.5  345.5 ± 92.4 
 Mean ± SD  335.5 ± 93.7  345.3 ± 99.8 
 
Saccade Amplitude (°)    
 Meds OFF    15.0 ± 2.1    16.0 ± 1.3    15.49 ± 1.7 
 Meds ON    15.8 ± 2.5    16.3 ± 3.2    16.02 ± 5.7 
 Mean ± SD    15.4 ± 2.3    16.1 ± 2.2     
Values are means ± standard deviations. 














Table 3. Kinematic Performance Data 
             
    DBS OFF  DBS ON  Mean   
Eye-Head Latency (ms) 
 Meds OFF  320.3 ± 275.6  168.9 ± 133.6  244.6 ± 204.6
 Meds ON  261.2 ± 143.5  151.9 ± 102.8  206.6 ± 123.2 
 Mean ± SD  290.8 ± 209.6      * 160.4 ± 118.2 
 
Head-Trunk Latency (ms) 
 Meds OFF  71.5 ± 115.1  11.8 ± 48.2  41.7 ± 81.6 
 Meds ON  55.7 ± 62.6  27.4 ± 62.7  41.6 ± 62.6 
 Mean ± SD  63.6 ± 88.8      * 19.6 ± 55.5 
 
Eye-Foot Latency (ms) 
 Meds OFF  667.2 ± 438.1  334.5 ± 289.8  500.9 ± 364.0 
 Meds ON  569.2 ± 527.3  248.7 ± 174.3  409.0 ± 350.8  
 Mean ± SD  618.2 ± 482.7       * 291.6 ± 232.1 
 
N. Eye-Head Latency (% First Gait cycle)  
 Meds OFF  306.8 ± 179.4  247.4 ± 277.4  277.1 ± 228.4 
 Meds ON  269.0 ± 96.4  190.2 ± 92.2  229.6 ± 94.3 
 Mean ± SD  287.9 ± 137.7  218.8 ± 184.6   
 
N. Eye-Foot Latency (% First Gait cycle)  
 Meds OFF  48.8 ± 33.5  59.9 ± 76.7  54.3 ± 55.1 
 Meds ON  59.0 ± 47.0  33.2 ± 24.8  46.1 ± 35.9 
 Mean ± SD    54.4 ± 40.3  46.51 ± 50.8 
 
N. Head-Trunk Latency (% First Gait cycle)   
 Meds OFF    7.5 ± 12.1    2.7 ± 6.6  5.1 ± 9.3 
 Meds ON    7.3 ± 8.0    3.6 ± 6.0  5.5 ± 7.0 
 Mean ± SD    7.4 ± 10.0     *   3.2 ± 6.3 
 
N. Head-Foot Latency (% First Gait cycle)  
 Meds OFF  18.2 ± 29.2  35.1 ± 49.9 26.6 ± 39.6 
 Meds ON  30.5 ± 40.4  15.7 ± 22.3  23.1 ± 31.4 
 Mean ± SD  16.9 ± 35.0  22.3 ± 33.0     
Values are means ± standard deviations. 
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Chapter 5: Conclusion 
Summary of Findings 
 Previous research has shown that individuals with PD suffer from bradykinesia 
that affects both the limbs and eyes.  Further, these patients also have difficulty switching 
between motor patterns which results in functional impairments such as turning difficulty 
and freezing of gait.  Previous work also demonstrated direction switching impairments 
in the upper extremity and during postural control tasks, but not yet in the eyes and lower 
limb.  In Chapter 2, we noted that the ability of individuals with PD to switch between 
movement orientations is in fact decreased during lower limb and oculomotor tasks, but 
that bradykinesia appears to be the underlying cause of this impairment.  Further, switch 
times correlated between eyes and lower limb, suggesting parallel declines in switching 
ability in the eyes and lower limb.   
 It is well known that the turning difficulty experienced by persons with PD is 
characterized by a more “en bloc” turning sequence.  However, it was previously unclear 
how eye movement function contributed to this impairment. In Chapter 3, we provided 
the first evidence that saccadic eye function is impaired in PD during turning and that the 
amount of oculomotor dysfunction is correlated with turn performance.  
 Improving turning in patients with PD may reduce the incidence of falls and 
injuries, yet the effect of interventions on turning is not understood.  As levodopa has the 
potential to improve saccades and DBS is widely accepted to do so, it was hypothesized 
in chapter 4 that such interventions may improve turning as well since turns are initi t d 
with a saccade.  Indeed, our findings show that levodopa improves turning duration, but 
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not related oculomotor function, while DBS has a strong influence on turning 
performance and the related oculomotor strategy. 
Significance and Clinical Implications  
 Taken together, these studies corroborate previous research that voluntary saccade
function is impaired in PD, and expand on these finding by delineating how dysfunctional 
saccades affect a functional task (turning). Studying the oculomotor system and rel ted 
dysfunction in PD has offered us a better understanding of basal ganglia funct on and 
dysfunction.  As the oculomotor system is simple and largely understood, it is well suit d 
for studying behavior in a controlled and systematic manner, free from many confounders 
often involved in the study of more complex motor symptoms.  However, many 
conclusions drawn from oculomotor research lack apparent or immediate therapeutic 
relevance and may not have implications that will improve function and quality of life in 
persons with PD.  In contrast, our findings bridge the gap between oculomotor 
impairments and systemic motor function and may have implications for clinical care.  
 One of the main implications of this research is that oculomotor dysfunction in 
PD correlates well with turning performance.  While identifying a cause nd effect 
relationship was beyond the scope of this work, our shown association between saccades 
and turning provides rationale for targeting the oculomotor system with therapeutic 
interventions and rehabilitation.  For example, it is well known that both internally ad 
externally generated cues can improve motor function in PD.  Visual cues, such as lines 
on the floor, increase stride length and velocity during gait, and auditory cues have hown 
similar benefits.1-5 Cues are also efficacious in ceasing episodes of freezing.6   I  light of 
this, and since saccade function is largely maintained in the presence of visual triggering, 
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the possibility of cueing the oculomotor system to improve turning performance is 
apparent.  Since individuals with PD initiate the turn sequence with a smaller saccade 
than age-matched controls, a potential cueing strategy could include a large saccade to a 
lateral target before initiating the turn sequence. This may elicit a more-top down rotation 
sequence. 
 A second implication of this research relates to the importance of understanding 
how medications and DBS affect the whole spectrum of functional impairments in PD.  
This work adds to this understanding by providing insights into the effects of these two 
interventions on turning. While symptoms such as tremor, forward gait, and non-motor 
complications may dominate for some patients, FOG and TD may be chief complaints of 
others.  The ability to tailor interventions on a patient-by-patient basis is paramount, but 
science is still working toward a full understanding of how each intervention affects PD, 
both positively and negatively.  Our results add rationale for STN DBS as therapy fo  
patients whose symptoms include TD.  Further, our results suggest a potential mech nism 
for the observed improvements in turning through facilitation of saccades. 
Limitations 
 One limitation of this work is that it is correlative in nature.  While we have 
shown that saccade function relates to turning performance and that DBS improves both, 
our results do not tell us if oculomotor control independently controls turning 
performance nor whether improving oculomotor control improves turning independent of 
other factors.  Secondly, turning in these studies was limited to in-place turns as opposed 
to turns during gait.  It is possible that differences exist between in-placing turning and 
turning in the midst of walking.  Finally, all observations were performed in a laboratory 
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environment and participants were aware they were being monitored.  It is possible that 
motor strategies used outside the laboratory may differ from those measured within the 
laboratory. 
Suggestions for Future Research 
 The influence of the oculomotor system on functional tasks is still poorly 
understood.  While we demonstrate herein that saccade function is correlated with turn 
performance, we do not provide sufficient evidence to support causality. Therefore, 
future studies should aim to answer whether saccades that occur during turning do in fact 
affect turn performance. This may be achieved by manipulating the paramete s of he 
initial saccade such as the amplitude or timing relative to turn onset. Further, locomotor 
tasks such as obstacle navigation, crossing barriers, and walking through narrow passages 
often invoke freezing in persons with PD.  It is possible that the oculomotor strategy us d 
during these situations differs in PD, perhaps by focusing attention on a different part of 
the environment or using a temporal scanning sequence that differs from controls.  If 
such were the case, it would again be interesting to modify subjects’ oculomotor strategy 
and measure subsequent changes in task performance.   
 Secondly, the effect of rehabilitative interventions, such as visual cueing, on 
turning has not yet been addressed.  Since cueing has shown great promise in improving 
locomotion in PD, a study of the effects of oculomotor cueing on turning is warranted. 
This could include both externally generated visual cues as well as internally generated 
cues such as thinking about making a larger saccade prior to turning.  
 Finally, since neurons related to oculomotor function are largely sequestered in 
the ventral region of the STN, research into the differential effects of dorsal vs. ventral 
97 
 
stimulation of the STN on oculomotor performance and subsequent turning performance 
would be beneficial.  Such data could provide additional rationale for specific electrod  
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